Gamma-secretase complex: molecular characterization, and moduation of enzymatic activity

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/400073

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A small protein fragment terned A-beta accumulates as amyloid plaques in the brain of patients with Alzheimer's disease. A-beta is toxic, it causes degeneration of brain cells, and it is believed to be the primary cause of Alzheimer's disease. Therefore, developing strategies to reduce the amounts of A-beta in the brain constitutes a rational therapeutic approach. A-beta is produced from a precursor protein by two cleaving enzymes that operate in a sequential order: these are termed beta and gamma-secretases. Gamma-secretase carries out the second and final step in the release of A-beta peptide, and it is a determining factor since it can create A-beta fragments of different lengths and with different toxic properties. Our group studies the biochemical characteristics of gamma-secretase, and the factors that regulate its activity to uncover novel therapeutic leads. In this project we will 1) investigate the molecular composition of gamma-secretase using biochemical methods 2) study the importance of the two components of gamma-secretase, termed APH-1 and nicastrin, for the enzymatic activity 3) analyse the mechanism of mutations in the A-beta precursor protein that occur at or near the gamma-secretase site of cleavage and cause familial Alzheimer's disease 4) search for factors that regulate gamma-secretase activity using a genetic screen approach. The results of the proposed experiments will provide information to help design new therapeutic strategies for Alzheimer's disease, an illness that afflicts a large proportion of the ageing population and places a major socio-economic burden upon our society.

Funded Activity Details

Start Date: 01-01-2006

End Date: 01-01-2008

Funding Scheme: NHMRC Project Grants

Funding Amount: $526,517.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Age-related degenerative diseases | Alzheimer disease | Alzheimer's disease | Molecular basis of disease | Therapeutic target | amyloid precursor protein | gene expression | membrane protein | protease

Related Links